Sun Pharma Advanced Research Company Limited

NSEI:SPARC Stock Report

Market Cap: ₹70.1b

Sun Pharma Advanced Research Balance Sheet Health

Financial Health criteria checks 3/6

Sun Pharma Advanced Research has a total shareholder equity of ₹1.3B and total debt of ₹611.5M, which brings its debt-to-equity ratio to 48.6%. Its total assets and total liabilities are ₹5.2B and ₹3.9B respectively.

Key information

48.6%

Debt to equity ratio

₹611.51m

Debt

Interest coverage ration/a
Cash₹1.57b
Equity₹1.26b
Total liabilities₹3.89b
Total assets₹5.15b

Recent financial health updates

Recent updates

Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans

Jan 17
Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans

Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't

Nov 14
Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't

Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?

Sep 05
Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?

Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation

Jun 27
Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation

Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?

Nov 23
Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?

If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%

Feb 08
If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%

Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?

Dec 14
Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?

Financial Position Analysis

Short Term Liabilities: SPARC's short term assets (₹2.7B) exceed its short term liabilities (₹2.7B).

Long Term Liabilities: SPARC's short term assets (₹2.7B) exceed its long term liabilities (₹1.2B).


Debt to Equity History and Analysis

Debt Level: SPARC has more cash than its total debt.

Reducing Debt: SPARC's debt to equity ratio has increased from 0.6% to 48.6% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SPARC has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: SPARC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.2% each year


Discover healthy companies